Microwave ablation instrument with flexible antenna assembly and method

Information

  • Patent Grant
  • 7301131
  • Patent Number
    7,301,131
  • Date Filed
    Thursday, February 16, 2006
    18 years ago
  • Date Issued
    Tuesday, November 27, 2007
    16 years ago
Abstract
A flexible microwave antenna assembly for a surgical ablation instrument capable of conforming to a tissue surface for ablation thereof. The ablation instrument includes a transmission line having a proximal portion suitable for connection to an electromagnetic energy source. The antenna assembly includes a flexible antenna coupled to the transmission line for radially generating an electric field sufficiently strong to cause tissue ablation. A flexible shield device is coupled to the antenna to substantially shield a surrounding area of the antenna from the electric field radially generated therefrom while permitting a majority of the field to be directed generally in a predetermined direction. A flexible insulator is disposed between the shield device and the antenna which defines a window portion enabling the transmission of the directed electric field in the predetermined direction. The antenna, the shield device and the insulator are formed for selective manipulative bending thereof, as a unit, to one of a plurality of contact positions to generally conform the window portion to the biological tissue surface to be ablated.
Description
BACKGROUND OF THE INVENTION

1. Field of Invention


The present invention relates, generally, to ablation instrument systems that use electromagnetic energy in the microwave frequencies to ablate internal bodily tissues, and, more particularly, to antenna arrangements and instrument construction techniques that direct the microwave energy in selected directions that are relatively closely contained along the antenna.


2. Description of the Prior Art


It is well documented that atrial fibrillation, either alone or as a consequence of other cardiac disease, continues to persist as the most common cardiac arrhythmia. According to recent estimates, more than two million people in the U.S. suffer from this common arrhythmia, roughly 0.15% to 2.0% of the population. Moreover, the prevalence of this cardiac disease increases with age, affecting nearly 8% to 17% of those over 60 years of age.


Atrial arrhythmia may be treated using several methods. Pharmacological treatment of atrial fibrillation, for example, is initially the preferred approach, first to maintain normal sinus rhythm, or secondly to decrease the ventricular response rate. Other forms of treatment include chemical cardioversion to normal sinus rhythm, electrical cardioversion, and RF catheter ablation of selected areas determined by mapping. In the more recent past, other surgical procedures have been developed for atrial fibrillation, including left atrial isolation, transvenous catheter or cryosurgical ablation of His bundle, and the Corridor procedure, which have effectively eliminated irregular ventricular rhythm. However, these procedures have for the most part failed to restore normal cardiac hemodynamics, or alleviate the patient's vulnerability to thromboembolism because the atria are allowed to continue to fibrillate. Accordingly, a more effective surgical treatment was required to cure medically refractory atrial fibrillation of the heart.


On the basis of electrophysiologic mapping of the atria and identification of macroreentrant circuits, a surgical approach was developed which effectively creates an electrical maze in the atrium (i.e., the MAZE procedure) and precludes the ability of the atria to fibrillate. Briefly, in the procedure commonly referred to as the MAZE III procedure, strategic atrial incisions are performed to prevent atrial reentry and allow sinus impulses to activate the entire atrial myocardium, thereby preserving atrial transport function postoperatively. Since atrial fibrillation is characterized by the presence of multiple macroreentrant circuits that are fleeting in nature and can occur anywhere in the atria, it is prudent to interrupt all of the potential pathways for atrial macroreentrant circuits. These circuits, incidentally, have been identified by intraoperative mapping both experimentally and clinically in patients.


Generally, this procedure includes the excision of both atrial appendages, and the electrical isolation of the pulmonary veins. Further, strategically placed atrial incisions not only interrupt the conduction routes of the common reentrant circuits, but they also direct the sinus impulse from the sinoatrial node to the atrioventricular node along a specified route. In essence, the entire atrial myocardium, with the exception of the atrial appendages and the pulmonary veins, is electrically activated by providing for multiple blind alleys off the main conduction route between the sinoatrial node to the atrioventricular node. Atrial transport function is thus preserved postoperatively as generally set forth in the series of articles: Cox, Schuessler, Boineau, Canavan, Cain, Lindsay, Stone, Smith, Corr, Change, and D'Agostino, Jr., The Surgical Treatment Atrial Fibrillation (pts. 1-4), 101 THORAC CARDIOVASC SURG., 402-426, 569-592 (1991).


While this MAZE III procedure has proven effective in ablating medically refractory atrial fibrillation and associated detrimental sequelae, this operational procedure is traumatic to the patient since substantial incisions are introduced into the interior chambers of the heart. Consequently, other techniques have thus been developed to interrupt and redirect the conduction routes without requiring substantial atrial incisions. One such technique is strategic ablation of the atrial tissues through ablation catheters.


Most approved ablation catheter systems now utilize radio frequency (RF) energy as the ablating energy source. Accordingly, a variety of RF based catheters and power supplies are currently available to electrophysiologists. However, radio frequency energy has several limitations including the rapid dissipation of energy in surface tissues resulting in shallow “burns” and failure to access deeper arrhythmic tissues. Another limitation of RF ablation catheters is the risk of clot formation on the energy emitting electrodes. Such clots have an associated danger of causing potentially lethal strokes in the event that a clot is dislodged from the catheter.


As such, catheters which utilize electromagnetic energy in the microwave frequency range as the ablation energy source are currently being developed. Microwave frequency energy has long been recognized as an effective energy source for heating biological tissues and has seen use in such hyperthermia applications as cancer treatment and preheating of blood prior to infusions. Accordingly, in view of the drawbacks of the traditional catheter ablation techniques, there has recently been a great deal of interest in using microwave energy as an ablation energy source. The advantage of microwave energy is that it is much easier to control and safer than direct current applications and it is capable of generating substantially larger lesions than RF catheters, which greatly simplifies the actual ablation procedures. Such microwave ablation systems are described in the U.S. Pat. No. 4,641,649 to Walinsky; U.S. Pat. No. 5,246,438 to Langberg; U.S. Pat. No. 5,405,346 to Grundy, et al.; and U.S. Pat. No. 5,314,466 to Stem, et al, each of which is incorporated herein by reference.


Most of the existing microwave ablation catheters contemplate the use of longitudinally extending helical antenna coils that direct the electromagnetic energy in a radial direction that is generally perpendicular to the longitudinal axis of the catheter although the fields created are not well constrained to the antenna itself. Although such catheter designs work well for a number of applications, such as radial output, they are inappropriate for use in precision surgical procedures. For example, in MAZE II surgical procedures, very precise and strategic lesions must be formed in the heart tissue which the existing microwave ablation catheters are incapable of delivering.


Consequently, microwave ablation instruments have recently been developed which incorporate microwave antennas having directional reflectors. Typically, a tapered directional reflector is positioned peripherally around the microwave antenna to direct the waves toward and out of a window portion of the antenna assembly. These ablation instruments, thus, are capable of effectively transmitting electromagnetic energy in a more specific direction. For example, the electromagnetic energy may be transmitted generally perpendicular to the longitudinal axis of the catheter but constrained to a selected angular section of the antenna, or directly out the distal end of the instrument. Typical of these designs are described in the U.S. patent application Ser. No. 09/178,066, filed Oct. 23, 1998; and Ser. No. 09/333,747, filed Jun. 14, 1999, each of which is incorporated herein by reference.


In these designs, the of the microwave antenna is preferably tuned assuming contact between the targeted tissue and a contact region of the antenna assembly extending longitudinally adjacent to the antenna longitudinal axis. Hence, should a portion of, or substantially all of, the exposed contact region of the antenna not be in contact with the targeted tissue during ablation, the adaptation of the antenna will be adversely changed and the antenna will be untuned. As a result, the portion of the antenna not in contact with the targeted tissue will radiate the electromagnetiz radiation into the surrounding air. The efficiency of the energy delivery into the tissue will consequently decrease which in turn causes the penetration depth of the lesion to decrease.


This is particularly problematic when the tissue surfaces are substantially curvilinear, or when the targeted tissue for ablation is difficult to access. Since these antenna designs are generally relatively rigid, it is often difficult to maneuver substantially all of the exposed contact region of the antenna into abutting contact against the targeted tissue. In these instances, several ablation instruments, having antennas of varying length and shape, may be necessary to complete just one series of ablations.


SUMMARY OF THE INVENTION

Accordingly, a flexible microwave antenna assembly is provided for a surgical ablation instrument adapted to ablate a surface of a biological tissue. The ablation instrument includes a transmission line having a proximal portion suitable for connection to an electromagnetic energy source. The antenna assembly includes a flexible antenna coupled to the transmission line for radially generating an electric field sufficiently strong to cause tissue ablation. A flexible shield device is coupled to the antenna to substantially shield a surrounding area of the antenna from the electric field radially generated therefrom while permitting a majority of the field to be directed generally in a predetermined direction. A flexible insulator is disposed between the shield device and the antenna which defines a window portion enabling the transmission of the directed electric field in the predetermined direction. In accordance with the present invention, the antenna, the shield device and the insulator are formed for selective manipulative bending thereof, as a unit, to one of a plurality of contact positions to generally conform the window portion to the biological tissue surface to be ablated.


In one configuration, a longitudinal axis of the antenna is off-set from a longitudinal axis of the insulator to position the antenna substantially proximate to and adjacent the window portion. The shield device is in the shape of a semi-cylindrical shell having a longitudinal axis generally co-axial with a longitudinal axis of the insulator.


In another embodiment, the insulator defines a receiving passage formed for sliding receipt of the antenna longitudinal therein during manipulative bending of the antenna assembly. Moreover, a polyimide tube device may be positioned in the receiving passage proximate the distal end of the antenna. The tube provides a bore formed and dimensioned sliding longitudinal reciprocation therein of at least the distal end of the antenna.


Another embodiment of the present invention provides an elongated, bendable, retaining member adapted for longitudinal coupling therealong to the insulator. This bendable retaining member enables the insulator to retain the one contact position after manipulative bending thereof for the conformance of the window portion to the biological tissue surface to be ablated. The retaining member is preferably disposed longitudinally along the insulator, and on one the of the shield device, while the antenna is preferably disposed on an opposite side of the shield device, longitudinally along the insulator, and between the shield device and the window portion.


In another aspect of the present invention provides a microwave ablation instrument, adapted to ablate a surface of a biological tissue, is provided having a handle member formed for manual manipulation of the ablation instrument. An elongated transmission line is provided coupled to the handle member. A proximal portion of the transmission line is suitable for connection to an electromagnetic energy source. The ablation instrument further includes a flexible antenna assembly coupled to the handle member which is formed for selective manipulative bending thereof. The antenna assembly includes a flexible antenna coupled to the transmission line for radially generating an electric field sufficiently strong to cause tissue ablation. A flexible shield device of the antenna assembly is employed to substantially shield a surrounding radial area of the antenna from the electric field radially generated therefrom, while permitting a majority of the field to be directed generally in a predetermined direction. A flexible insulator is disposed between the shield device and the antenna, and defines a window portion enabling the transmission of the directed electric field in the predetermined direction. The antenna, the shield device and the insulator are formed for selective manipulative bending thereof, as a unit, to one of a plurality of contact positions to generally conform the window portion to the biological tissue surface to be ablated.


In this configuration, the ablation instrument may include a bendable, malleable shaft having a proximal portion coupled to the handle member, and an opposite a distal portion coupled to the antenna assembly. The shaft is preferably a semi-rigid coaxial cable, but may also include a tubular shaft where the transmission line may be disposed therethrough from the proximal portion to the distal portion thereof. The shaft is preferably conductive having a distal portion conductively coupled to the proximal end of the shield device, and another portion conductively coupled to the outer conductor of the transmission line.


In another embodiment, a restraining sleeve is adapted to limit the bending movement of the bendable antenna assembly at the conductive coupling between the shield device and the shaft. The restraining sleeve is formed and dimensioned to extend peripherally over the conductive coupling to limit the bending movement in a predetermined direction to maintain the integrity of conductive coupling. The restraining sleeve includes a curvilinear transverse cross-sectional dimension extending past the conductive coupling longitudinally therealong by an amount sufficient to maintain the integrity.


In still another configuration, an elongated grip member is included having a distal grip portion and an opposite proximal portion coupled to a distal portion of the antenna assembly. The grip member and the handle member cooperate to selectively bend the antenna assembly and selectively urge the window portion in abutting contact with the biological tissue surface to be ablated. The gripping member is preferably provided by an elongated flexible rod having a diameter smaller than a diameter of the insulator. A longitudinal axis of the flexible rod is off-set from the longitudinal axis of the insulator to position the rod in general axial alignment with the antenna, and adjacent the window portion.


In still another aspect of the present invention, a method is provided for ablating medically refractory atrial fibrillation of the heart including the step of providing a microwave ablation instrument having a flexible antenna assembly adapted to generate an electric field sufficiently strong to cause tissue ablation. The antenna assembly defines a window portion enabling the transmission of the electric field there through in a predetermined direction. The method further includes selectively bending and retaining the flexible antenna assembly in one of a plurality of contact positions to generally conform the shape of the window portion to the targeted biological tissue surface to be ablated, and manipulating the ablation instrument to strategically position the conformed window portion into contact with the targeted biological tissue surface. The next step includes forming an elongated lesion in the targeted biological tissue surface through the generation of the electric field by the antenna assembly.


These bending, manipulating and generating events are preferably repeated to form a plurality of strategically positioned ablation lesions. Collectively, these lesions are formed to create a predetermined conduction pathway between a sinoatrial node and an atrioventricular node of the heart.





BRIEF DESCRIPTION OF THE DRAWINGS

The assembly of the present invention has other objects and features of advantage which will be more readily apparent from the following description of the best mode of carrying out the invention and the appended claims, when taken in conjunction with the accompanying drawing, in which:



FIG. 1 is a diagrammatic top plan view of a microwave ablation instrument system with a bendable directional reflective antenna assembly constructed in accordance with one embodiment of the present invention.



FIG. 2 is an enlarged, fragmentary, top perspective view of the antenna assembly of FIG. 1 mounted to a distal end of a handle member of the ablation instrument.



FIG. 3 is an enlarged, fragmentary, top perspective view of the antenna assembly of FIG. 1 illustrated in a bent position to conform to a surface of the tissue to be ablated.



FIG. 4 is an enlarged, fragmentary, top perspective view of the antenna assembly of FIG. 2 illustrated in another bent position to conform to a surface of the tissue to be ablated.



FIG. 5 is an enlarged, fragmentary, top plan view of the antenna assembly of FIG. 2 illustrating movement between a normal position (phantom lines) and a bent position (solid lines).



FIG. 6 is a fragmentary side elevation view of the antenna assembly of FIG. 5.



FIG. 7 is an enlarged, front elevation view, in cross-section, of the antenna assembly taken substantially along the plane of the line 7-7 in FIG. 6.



FIG. 8 is an enlarged, fragmentary, side elevation view of the antenna assembly of FIG. 2 having a restraining sleeve coupled thereto.



FIG. 9 is an enlarged, front elevation view, in cross-section, of the antenna assembly taken substantially along the plane of the line 9-9 in FIG. 8.



FIG. 10 is a diagrammatic top plan view of an alternative embodiment microwave ablation instrument system constructed in accordance with one embodiment of the present invention.



FIG. 11 is a reduced, fragmentary, top perspective view of the antenna assembly of FIG. 10 illustrated in a bent position to conform to a surface of the tissue to be ablated.



FIG. 12 is a reduced, fragmentary, top perspective view of an alternative embodiment antenna assembly of FIG. 10 having a flexible handle member.





DETAILED DESCRIPTION OF THE INVENTION

While the present invention will be described with reference to a few specific embodiments, the description is illustrative of the invention and is not to be construed as limiting the invention. Various modifications to the present invention can be made to the preferred embodiments by those skilled in the art without departing from the true spirit and scope of the invention as defined by the appended claims. It will be noted here that for a better understanding, like components are designated by like reference numerals throughout the various Figures.


Turning now to FIGS. 1-4, a microwave ablation instrument, generally designated 20, is provided which is adapted to ablate a surface 21 of a biological tissue 22. The ablation instrument 20 includes a handle member 23 formed to manually manipulate the instrument during open surgery. An elongated transmission line 25 is provided coupled to the handle member 23 at a distal portion thereof, and having a proximal portion suitable for connection to an electromagnetic energy source (not shown). The ablation instrument 20 further includes a flexible antenna assembly, generally designated 26, coupled to the handle member 23 and to the transmission line 25 to generate an electric field. The antenna assembly 26 is adapted to transmit an electric field out of a window portion 27 thereof in a predetermined direction sufficiently strong to cause tissue ablation. The antenna assembly is further formed for selective manipulative bending to one of a plurality of contact positions (e.g., FIGS. 3 and 4) to generally conform the window portion 27 to the biological tissue surface 21 to be ablated.


More specifically, the flexible antenna assembly 26 includes a flexible antenna 28 coupled to the transmission line 25 for radially generating the electric field substantially along the longitudinal length thereof. A flexible shield device 30 substantially shields a surrounding radial area of the antenna wire 28 from the electric field radially generated therefrom, while permitting a majority of the field to be directed generally in a predetermined direction toward the window portion 27. A flexible insulator 31 is disposed between the shield device 30 and the antenna 28, and defines the window portion 27 enabling the transmission of the directed electric field in the predetermined direction. The antenna 28, the shield device 30 and the insulator 31 are formed for selective manipulative bending thereof, as a unit, to one of a plurality of contact positions to generally conform the window portion 27 to the biological tissue surface 21 to be ablated.


Accordingly, the microwave ablation instrument of the present invention enables manipulative bending of the antenna assembly to conform the window portion to the biological tissue surface to be ablated. This ensures a greater degree of contact between the elongated window portion and the targeted tissue. This is imperative to maintain the radiation efficiency of the antenna, and thus, proper tuning for more efficient microwave transmission. Such manipulative bending also substantially increases the versatility of the instrument since one antenna assembly can be configured to conform to most tissue surfaces.


Briefly, the ablation instrument 20 includes a handle member 23 coupled to the antenna assembly 26 through an elongated tubular shaft or semi-rigid coaxial cable, hereinafter referred to as shaft 32. By manually manipulating the handle, the window portion 27 of the antenna assembly 26 may be oriented and positioned to perform the desired ablation. As mentioned, the shaft 32 is preferably provided a semi-rigid coaxial cable or by a conductive material such as a metallic hypotube which is mounted to the components of the antenna assembly 26 through brazing paste, welding or the like, as will be discussed. Accordingly, when the shaft 32 is provided by the semi-rigid coaxial cable, the braided outer conductor 29 of the semi-rigid coaxial cable 32, peripherally surrounding the center conductor 33, is preferably conductively coupled to the outer conductor of the transmission line 25. Similarly, the inner conductor 33 of the semi-rigid coaxial cable 32 is conductively coupled to the inner conductor of the transmission line 25.


In contrast, when the shaft 32 is provided by the tubular, such as a conductive hypotube, the solid cylindrical shell outer conductor 29 thereof is preferably conductively coupled to the outer conductor of the transmission line 25. In this configuration, the inner conductor and the insulator of the transmission line extend through the cylindrical shell outer conductor 29 of the conductive hypotube 32 to provide the inner conductor 33 thereof. In this manner, the metallic hypotube itself functions as the outer conductor of the transmission line 25 for shielding along the length of the shaft.


Moreover, the shaft 32, whether the hypotube or the semi-rigid coaxial cable, is preferably bendable and malleable in nature to enable shape reconfiguration to position the antenna assembly at a desired orientation relative the handle. This permits the surgeon to appropriately angle the window portion toward the targeted region for tissue ablation. It will be appreciated, however, that the material of the shaft 32 is further sufficiently rigid so that the shaft is not easily deformed during operative use. Such materials for the hypotube, for example, include stainless steel or aluminum having diameters ranging from about 0.090 inches to about 0.200 inches with wall thickness ranging from about 0.010 inches to about 0.050 inches. When the semi-coaxial cable is applied as the shaft 32, the outer diameter of the outer conductor ranges from about 0.090 inches to about 0.200 inches, with wall thickness ranging from about 0.010 inches to about 0.050 inches; while the inner conductor includes a diameter in the range of about 0.010 inches to about 0.050 inches.


The transmission line 25 is typically coaxial, and is coupled to a power supply (not shown) through connector 35 (FIG. 1). As best illustrated in FIGS. 2 and 5-7, the microwave ablation instrument 20 generally includes an elongated antenna wire 28 having a proximal end attached to center conductor 33 of transmission line 25. These linear wire antennas radiate a cylindrical electric field pattern consistent with the length thereof. It will be appreciated, however, that the antenna may be any other configuration, as well, such as a helical or coiled antenna.


The electrical interconnection between the antenna wire 28 and the distal end of the center conductor 33 may be made in any suitable manner such as through soldering, brazing, ultrasonic welding or adhesive bonding. Moreover, the antenna wire 28 may be an extension of the center conductor of the transmission line itself which has the advantage of forming a more rugged connection therebetween. Typically, the antenna wire 28 is composed of any suitable material, such as spring steel, beryllium copper, or silver-plated copper.


As will be discussed in greater detail below, the diameter of the antenna wire may vary to some extent based on the particular application of the instrument. By way of example, an instrument suitable for use in an atrial fibrillation application may have typical diameter in the range of approximately 0.005 to 0.030 inches. More preferably, the diameter of antenna wire may be in the range of approximately 0.013 to 0.020 inches.


The antenna 28 is designed to have a good radiation efficiency and to be electrically balanced. Consequently, the energy delivery efficiency of the antenna is increased, while the reflected microwave power is decreased which in turn reduces the operating temperature of the transmission line. Moreover, the radiated electromagnetic field is substantially constrained from the proximal end to the distal end of the antenna. Thus, the field extends substantially radially perpendicularly to the antenna and is fairly well constrained to the length of the antenna itself regardless of the power used. This arrangement serves to provide better control during ablation. Instruments having specified ablation characteristics can be fabricated by building instruments with different length antennas.


Briefly, the power supply (not shown) includes a microwave generator which may take any conventional form. When using microwave energy for tissue ablation, the optimal frequencies are generally in the neighborhood of the optimal frequency for heating water. By way of example, frequencies in the range of approximately 800 MHz to 6 GHz work well. Currently, the frequencies that are approved by the U.S. Food and Drug Administration for experimental clinical work are 915 MHz and 2.45 GHz. Therefore, a power supply having the capacity to generate microwave energy at frequencies in the neighborhood of 2.45 GHz may be chosen. A conventional magnetron of the type commonly used in microwave ovens is utilized as the generator. It should be appreciated, however, that any other suitable microwave power source could be substituted in its place, and that the explained concepts may be applied at other frequencies like about 434 MHz, 915 MHz or 5.8 GHz (ISM band).


Referring back to FIGS. 1-5, the microwave ablation instrument 20 of the present invention will be described in detail. As above-mentioned, the antenna wire 28, the shield device 30 and the insulator 31 of the antenna assembly cooperate, as a unit, to enable selective manipulative bending thereof to one of a plurality of contact positions to generally conform the window portion 27 to the biological tissue surface 21 to be ablated. Thus, FIGS. 3 and 4 illustrate two particular contact positions where the window portion 27 may be configured to maintain contact for substantially curvilinear tissue surfaces 21. Consequently, due to the proper impedance matching between the medium of the insulator 31 and that of the biological tissue, contact therebetween along the window portion 27 is necessary to maintain the radiation efficiency of the antenna.


As above-mentioned, a flexible shield device 30 extend substantially along the length of the antenna substantially parallel to the longitudinal axis of the antenna in a normal unbent position (shown in solid lines in FIG. 2 and phantom lines in FIG. 5). The shield device 30 is formed and dimensioned to shield selected surrounding areas radially about the antenna wire 28 from the electric field radially generated therefrom, while reflecting the field and permitting the passage of the field generally in a predetermined direction toward the strategically located window portion 27 of the insulator 31. As best viewed in FIGS. 2, 7 and 9, the shield device 30 is preferably semi-cylindrical or arcuate-shaped in the transverse cross-sectional dimension to reflect the impinging field back toward the antenna thereof.


Tissue ablation can thus be more strategically controlled, directed and performed without concern for undesirable ablation of other adjacent tissues which may otherwise be within the electromagnetic ablation range radially emanating from the antenna. In other words, any other tissues surrounding the peripheral sides of the antenna which are out of line of the window portion of the cradle will not be subjected to the directed electric field and thus not be ablated. This ablation instrument assembly is particularly suitable for ablation procedures requiring accurate tissue ablations such as those required in the MAZE III procedure above-mentioned.


Briefly, it will be appreciated that the phrase “peripheral area immediately surrounding the antenna” is defined as the immediate radial transmission pattern of the antenna which is within the electromagnetic ablation range thereof when the shield assembly is absent.


The shield device 30 is preferably composed of a high conductivity metal to provide superior microwave reflection. The walls of the shield device 30, therefore, are substantially impenetrable to the passage of microwaves emanating from the antenna 28 to protect a backside of the antenna assembly from microwave exposure. More specifically, when an incident electromagnetic wave originating from the antenna reaches the conductive shield device, a surface current is induced which in turn generates a responsive electromagnetic field that will interfere with that incident field. Consequently, this incident electromagnetic field together with the responsive electromagnetic field within the shield device 30 of the antenna assembly 26 cancel and are thus negligible.



FIGS. 2 and 5 best illustrate that the shield device 30 is preferably provided by a braided conductive mesh having a proximal end conductively mounted to the distal portion of the outer conductor of the coaxial cable. This conductive mesh is preferably thin walled to minimize weight addition to the shield assembly yet provide the appropriate microwave shielding properties, as well as enable substantial flexibility of the shield device during bending movement. One particularly suitable material is stainless steel, for example, having mesh wires with a thickness in the range of about 0.005 inches to about 0.010 inches, and more preferably about 0.007 inches.


As mentioned, an elongated microwave antenna normally emits an electromagnetic field substantially radially perpendicular to the antenna length which is fairly well constrained to the length of the antenna wire regardless of the power used. However, to assure proper shielding, the longitudinal length of the shield may be longer than and extend beyond the distal and proximal ends of the antenna wire 28.


To maintain the electromagnetic field characteristics of the antenna during operative use, even with a flexible antenna, it is important to maintain the position of a transverse cross-sectional segment of shield device 30 relative a corresponding transverse cross-sectional segment of the antenna wire 28. Relative position changes between the segments may alter the radiation pattern and the radiation efficiency of the antenna. Accordingly, to stabilize these transverse cross-sectional segments of the shield device relative to the corresponding transverse cross-sectional segments of the antenna wire 28, the antenna assembly 26 includes the flexible insulator 31 preferably molded over and disposed between the shield device 30 and the antenna wire 28.


The insulator 31 is preferably further molded to the distal portion of the metallic tubular shaft, and is preferably cylindrical shaped having an axis generally coaxial with that of the shield device 30. The insulator 31 further performs the function of decreasing the coupling between the antenna 28 and the flexible shield device 30. Should the antenna 28 be too close to the conductive shield device 30, a strong current may be induced at the surface thereof. This surface current will increase the resistive losses in the metal and the temperature of the cradle device will increase. On the other hand, direct conductive contact or substantially close contact of the antenna with the metallic cradle device will cause the reflective cradle device to become part of the radiative structure, and begin emitting electromagnetic energy in all directions.


The insulator 31 is therefore preferably provided by a good, low-loss dielectric material which is relatively unaffected by microwave exposure, and thus capable of transmission of the electromagnetic field therethrough. Moreover, the insulator material preferably has a low water absorption so that it is not itself heated by the microwaves. Finally, the insulation material must be capable of substantial flexibility without fracturing or breaking. Such materials include moldable TEFLON®, silicone, or polyethylene, polyimide, etc.


In the preferred embodiment, the insulator 31 defines an elongated window portion 27 extending substantially adjacent and parallel to the antenna wire 28. Thus, as shown in FIGS. 5 and 7-9, a longitudinal axis of the antenna wire 28 is off-set from, but parallel to, the longitudinal axis of insulator 31 in a direction toward the window portion. This configuration positions the antenna wire 28 actively in the window portion 27 to maximize exposure of the targeted tissue to the microwaves generated by antenna, as well as further space the antenna sufficiently away from the shield device to prevent the above-mentioned electrical coupling.


In a normal unbent position of the antenna assembly 26 (shown in solid lines in FIG. 2 and phantom lines in FIG. 5), the window portion 27 is substantially planar and rectangular in shape. Upon bending thereof, however, the face of the window portion 27 can be manipulated to generally conform to the surface of the tissue 22 to be ablated. Thus, a greater degree of contact of a curvilinear surface 21 of a tissue 22 with full face of the window portion 27 is enabled. The radiation pattern along the antenna, therefore, will not be adversely changed and the antenna will remain tuned, which increases the efficiency and the penetration depth of the energy delivery into the tissue 22.


In accordance with the present invention, the window portion 27 is strategically sized and located relative the shield device to direct a majority of the electromagnetic field generally in a predetermined direction. As best viewed in FIGS. 2, 5 and 7, the window portion 27 preferably extends longitudinally along the insulator 31 in a direction substantially parallel to the longitudinal axis thereof. The length of the ablative radiation is therefore generally constrained to the length of the antenna wire 28, and may be adjusted by either adjusting the length of the antenna wire 28. To facilitate the coupling between the coaxial cable and the antenna wire, the proximal end of the window portion 27 generally extends proximally a little longer than the proximal end of the antenna 28 (about 2-5 mm). On the distal end, however, the window portion 27 is configured to approximate the length of the distal end of the shield device 30. Incidentally, as will be described in greater detail below, the distal portion of the shield device 30 extends well beyond the distal end of the antenna to accommodate for bending of the antenna assembly 26.



FIGS. 7 and 9 best illustrate that the radiation pattern of the electromagnetic field delivered from the window portion 27 may extend radially from about 120° to about 180°, and most preferably extend radially about 180°, relative the longitudinal axis of the insulator. Thus, a substantial portion of the backside of the antenna is shielded from ablative exposure of the microwaves radially generated by the antenna in directions substantially perpendicular to the longitudinal axis thereof. The circumferential dimension of window portion 27, hence, may vary according to the breadth of the desired ablative exposure without departing from the true spirit and nature of the present invention. Moreover, while a small percentage of the electromagnetic field, unshielded by the shield device, may be transmitted out of other non-window portions of the insulator, a substantial majority will be transmitted through the window portion. This is due to the impedance matching characteristics which are turned to contact between the tissue and the window portion.


Accordingly, the predetermined direction of the ablative electromagnetic field radially generated from the antenna may be substantially controlled by the circumferential opening dimension, the length and the shape of the window portion 27. Manipulating the shape of the antenna assembly 26 to conform the window portion generally to the shape of the targeted tissue surface, and positioning of window portion 27 in the desired direction for contact with the tissue, thus, controls the direction of the tissue ablation without subjecting the remaining peripheral area immediately surrounding the antenna to the ablative electromagnetic field.


In a preferred embodiment of the present invention, an elongated, bendable, retaining member, generally designated 36, is provided which is adapted for longitudinal coupling therealong to the insulator 31. Once the window portion 27 is manually manipulated for conformance to the biological tissue surface to be ablated, this bendable retaining member 36 functions to retain the insulator 31 in the one position for operative ablation thereof. As best viewed in FIGS. 2, 5 and 7, the retaining member 36 is preferably positioned behind the shield device 30 so as to be shielded from exposure to the microwaves transmitted by antenna 28. The retaining member preferably extends along the full length of the shield device in a direction substantially parallel to the longitudinal axis of the insulator 31.


This retaining member 36 must be a ductile or bendable material, yet provide sufficient rigidity after being bent, to resist the resiliency of the insulator to move from a bent position (e.g., FIGS. 3 and 4) back toward the normal position (FIG. 2). Moreover, both the retaining member 36 and the antenna wire 28 must not be composed of a material too rigid or brittle as to fracture or easily fatigue tear during repeated bending movement. Such materials for the retaining member include tin or silver plated copper or brass, having a diameter in the range of about 0.020 inch to about 0.050 inches.


In a preferred form, retaining member 36 is molded or embedded in the moldable insulator. This facilitates protection of the retaining member 36 from contact with corrosive elements during use. It will be appreciated, however, that retaining member 36 could be coupled to the exterior of the insulator longitudinally therealong.


As shown in FIGS. 2 and 5, a proximal portion of the retaining member 36 is positioned adjacent and substantially parallel to a distal portion of the shaft 32. Preferably, the proximal portion of the retaining member 36 is rigidly affixed to the distal portion of the shaft 32 at a coupling portion 41 thereof to provide relative stability between the shaft and the antenna assembly 26 during bending movement. While such rigid attachment is preferably performed through soldering, brazing, or ultrasonic welding, the coupling could be provided by a rigid, non-conductive adhesive or the like.


Preferably, the retaining member 36 is cylindrical-shaped, having a substantially uniform transverse cross-sectional dimension. It will be appreciated, however, that other geometric transverse cross-sectional dimensions may apply such as a rectangular cross-section. As shown in FIG. 9, this retaining member 36 is in the form of a thin metallic strip embedded atop the shield device 30. In this configuration, due to the relative orientation of the antenna and the shield device 30 bending in vertical direction, will be permitted while movement in a lateral side-to-side direction will be resisted. Moreover, the retaining member 36 may not be uniform in transverse cross-sectional dimension to permit varied rigidity, and thus variable bending characteristics, longitudinally along the antenna assembly.


In another alternative configuration, the retaining member 36 may be incorporated into the shield device or the antenna itself. In either of these configurations, or a combination thereof, the shield device and/or the antenna must provide sufficient rigidity to resist the resiliency of the insulator 31 to move from the bent position (e.g., FIGS. 3 and 4) back toward the normal position (FIG. 2).


In accordance with the present invention, the insulator 31 defines a receiving passage 37 formed for sliding receipt of the antenna wire 28 longitudinally therein during manipulative bending of the antenna assembly 26. As best viewed in FIGS. 5 and 6, this sliding reciprocation enables bending of the antenna assembly 26 without subjecting the antenna 28 to compression or distension during bending movement of the antenna which may ultimately fatigue or damage the antenna, or adversely alter the integrity of the electromagnetic field.


Such displacement is caused by the bending movement of the antenna assembly pivotally about the retaining member 36. For example, as shown in FIG. 7, during concave bending movement (FIGS. 2 and 5) or convex bending movement (FIG. 8) of the window portion 27 of the antenna assembly 26, the pivotal or bending movement will occur about the longitudinal axis of the retaining member 36. Accordingly, upon concave bending movement of the window portion 27 (FIGS. 2 and 5), the length of the receiving passage 37 shortens. This is due to the fact that the insulator 31 compresses at this portion thereof since the receiving passage 37 is positioned along the radial interior of the retaining member. Essentially, the radius of curvature of the receiving passage 37 is now less than the radius of curvature of the outer retaining member 36. However, the longitudinal length of the antenna 28 slideably retained in the receiving passage 37 will remain constant and thus slide distally into the receiving passage.


In contrast, upon convex bending movement of the window portion 27 (FIG. 8), the length of the receiving passage 37 distends since the receiving passage 37 will be positioned on the radial exterior of the retaining member 36. In this situation, the radius of curvature of the receiving passage 37 will now be greater than the radius of curvature of the outer retaining member 36. Consequently, the distal end of the antenna slides proximally in the receiving passage 37.


Preferably, the diameter of the receiving passage is about 5% to about 10% larger than that of the antenna wire 28. This assure uninterfered sliding reciprocation therein during bending movement of the antenna assembly 26. Moreover, the proximal end of the receiving passage 37 need not commence at the proximal end of the antenna wire 28. For instance, since the displacement at the proximal portion of the antenna wire 28 is substantially less than the displacement of the antenna wire 28 at a distal portion thereof, the proximal end of the receiving passage 37 may commence about 30% to about 80% from the proximal end of the antenna wire 28. The distal end of the receiving passage 37, on the other hand, preferably extends about 30% to about 40% past the distal end of the antenna wire 28 when the antenna assembly is in the normal unbent position. As above-indicated, this space in the receiving passage 37 beyond the distal end of the antenna 28 enables reciprocal displacement thereof during concave bending movement.


To assure that the distal end of the antenna 28 does not pierce through the relatively soft, flexible insulating material of the insulator 31, during bending movement, the tip portion thereof may be rounded or blunted. In another configuration, the receiving passage 37 may be completely or partially lined with a flexible tube device 38 (FIGS. 2 and 5-7) having a bore 39 formed and dimensioned for sliding longitudinal reciprocation of the antenna distal end therein. The walls of tube device 38 are preferably relatively thin for substantial flexibility thereof, yet provide substantially more resistance to piercing by the distal end of the antenna 28. Moreover, the material composition of the tube device must have a low loss-tangent and low water absorption so that it is not itself affected by exposure to the microwaves. Such materials include moldable TEFLON® and polyimide, polyethylene, etc.


Referring now to FIGS. 8 and 9, a restraining sleeve, generally designated 40, is provided which substantially prevents convex bending movement of the retaining member 36 at the proximal portion thereof. At this coupling portion 41, where the retaining member 36 and the shield device 30 are mounted to the distal portion of the shaft 32, repeated reciprocal bending in the convex direction may cause substantial fatigue of the bond, and ultimately fracture. The restraining sleeve 40, thus, preferably extends longitudinally over the coupling portion 41 to maintain the integrity of the coupling by preventing strains thereon. Essentially, such convex bending movement will then commence at a portion of the antenna assembly 26 distal to the coupling portion.


The restraining sleeve 40 includes an arcuate shaped base portion 42 removably mounted to and substantially conforming with the circumferential cross-sectional dimension of the proximal portion of the insulator 31 (FIG. 9). The base portion 42 is rigidly affixed to the antenna assembly and/or the shaft to provide protective stability over the coupling portion 41.


A finger portion 43 extends distally from the base portion 42 in a manner delaying the commencement of convex bending of the antenna assembly to a position past the distal end of the finger portion 43. Consequently, any strain upon the coupling portion 41 caused by convex bending movement of the antenna assembly is eliminated.


In another embodiment of the present invention, the microwave ablation instrument 20 includes an elongated grip member 45 having a distal grip portion 46 and an opposite proximal portion 47 coupled to a distal portion of the antenna assembly 26. As best illustrated in FIGS. 10 and 11, the grip member 45 and the handle member 23 of the ablation instrument 20 cooperates to selectively bend the flexible antenna assembly 26 and selectively urge the window portion 27 into abutting contact with the biological tissue surface to be ablated. For example, this application is particularly useful when the targeted tissue surface is located at a rear portion of an organ or the like. FIG. 11 illustrates that, during open procedures, the elongated grip member 45 may be passed around the backside of the organ until the window portion 27 of the antenna assembly is moved into abutting contact with the targeted tissue surface 21. Subsequently, the handle member 23 at one end of the ablation instrument, and the grip member 45 at the other end thereof are manually gripped and manipulated to urge the window portion 27 into ablative contact with the targeted tissue surface.


This configuration is beneficial in that the window portion 27 is adapted to conform to the tissue surface upon manual pulling of the grip member 45 and the handle member 23. As the flexible antenna assembly 26 contacts the targeted tissue 22, the window portion 27 thereof is caused to conform to the periphery of the tissue surface. Continued manipulation of the grip member 45 and the handle member 23 further urge bending contact. Accordingly, this embodiment will not require a retaining member for shape retention.


The elongated grip member 45 is provided by a substantially flexible rod having a diameter smaller than the diameter of the insulator 31. Such flexibility enables manipulation of the rod to position its distal end behind a targeted biological tissue 22. Once the distal grip portion 46 of the grip member 45 is strung underneath organ 22 or the like, the distal grip portion 46 may be gripped to pull the antenna assembly 26 behind the organ 22 for ablation of the targeted tissue.


It will be appreciated, however, that the rod 45 should not be substantially more flexible than that of the antenna assembly. This assures that the window portion 27 of the insulator 31 will be caused to conform to the curvilinear surface of the targeted tissue 22, as opposed to the mere bending of the flexible rod 45. Such materials for the flexible rod 45 includes Pebax filled with silicone and polyethylene, polyurethane, etc.


To mount flexible rod 48 to the ablation instrument 20, the antenna assembly 26 includes a mounting portion 48 extending distally from the insulator 31. This mounting portion 48 is preferably integrally formed with the insulator 31 and is of a sufficient length to enable the proximal portion of flexible rod 45 to be integrally molded thereto without interference with the shield device 30 and/or the antenna wire 28.


In the preferred embodiment, a longitudinal axis of the flexible rod 45 is off-set from the longitudinal axis of the insulator 31 in the direction toward the window portion 27. As viewed in FIG. 11, this off-set preferably positions the longitudinal axis of the flexible rod proximately in co-axial alignment with the antenna. This arrangement facilitates alignment of the window portion 27 against the targeted tissue 22 as the grip member 45 and the handle member 23 are manipulated to conform the window portion 27 with and against the tissue surface 21. Due to the off-set nature of the flexible rod 45, when the antenna assembly and the rod are tightened around the biological tissue 22, the antenna assembly 26 is caused to rotate about its longitudinal axis toward an orientation of least resistance (i.e., a position where the flexible rod 45 is closest to the biological tissue 22).


Additionally, as shown in FIG. 12, the handle member 23 may be elongated and substantially flexible in a manner similar to the elongated grip member 45. In another embodiment of the present invention, the handle member 23 includes a proximal grip portion 50 and an opposite distal portion 51 coupled to a proximal portion of the antenna assembly 26. Thus, the flexible handle member 23 and the flexible grip member 45 cooperate to selectively bend the flexible antenna assembly 26 and selectively urge the window portion 27 into abutting contact with the biological tissue surface to be ablated. As another example, this application is particularly useful for creating long continuous linear lesions (E.g., to enclose the pulmonary veins when treating atrial fibrillation or the like). The flexible handle member 23 at one end of the ablation instrument, and the flexible grip member 45 at the other end thereof are manually gripped and manipulated to urge the window portion 27 into ablative contact with the targeted tissue surface. This can be performed by simply sliding the antenna assembly 26 by pulling either the flexible grip member 45 or the flexible handle member 23 to position the widow portion 27 against the tissue. Moreover, this can be used to slightly overlap the lesions to generate a long continuous lesion without gaps easily end the targeted tissue surface is located at a rear portion of an organ or the like.


The elongated flexible handle member 23 is preferably provided by a substantially flexible coaxial cable appropriately coupled to the transmission line. In some instances, the handle member 23 may simply be an extension of the transmission line.


Preferably, the flexible coaxial cable handle member 23 is covered by a plastic sleeve such as Pebax, PE Polyolifin, etc. Such dual flexibility enables increased manipulation of both the gripping member and the handle member. To mount flexible handle member 23 to the antenna assembly 26, the distal portion thereof is preferably integrally formed with the insulator.


Similar to the gripping member 45, a longitudinal axis of the flexible handle member 23 is off-set from the longitudinal axis of the insulator 31 in the direction toward the window portion 27. As viewed in FIG. 12, this off-set, together with the same off-set of the gripping member, preferably positions the longitudinal axis of the handle member proximately in co-axial alignment with the antenna. This arrangement facilitates alignment of the window portion 27 against the targeted tissue 22 as the grip member 45 and the handle member 23 are manipulated to conform the window portion 27 with and against the tissue surface 21. Due to the off-set nature of the flexible rod 45, when the antenna assembly and the rod are tightened around the biological tissue 22, the antenna assembly 26 is caused to rotate about its longitudinal axis toward an orientation of least resistance (i.e., a position where the flexible rod 45 is closest to the biological tissue 22).


In still another aspect of the present invention, a method is provided for treatment of a heart including providing a microwave ablation instrument 20 having a flexible antenna assembly 26 defining a window portion 27 enabling the transmission of a directed electric field therethrough in a predetermined direction. By selectively bending the flexible antenna assembly 26 to one of a plurality of contact positions, the window portion 27 can be generally conformed to the shape of the targeted biological tissue 22 surface to be ablated. The method further includes manipulating the ablation instrument 20 to strategically position the conformed window portion 27 into contact with the targeted biological tissue surface 21; and generating the electric field sufficiently strong to cause tissue ablation to the targeted biological tissue surface 21.


More preferably, this method is directed toward medically refractory atrial fibrillation of the heart. By repeating the bending, manipulating and generating events, a plurality of strategically positioned ablation lesions can be accurately formed in the heart. Collectively, these lesions are formed to create a predetermined conduction pathway between a sinoatrial node and an atrioventricular node of the heart, or to divide the left and/or right atrium in order to avoid any reentry circuits.


These techniques may be preformed while the heart remains beating, such as in a minimally invasive heart procedure, while the heart is temporarily arrested, such as when the heart is stabilized for about 20 or 30 seconds during a cabbage procedure, or while the heart is arrested, such as in an open heart surgery. Moreover, these procedures may be applied to ablate the endocardium as well as the epicardium in order to treat atrial fibrillation throughout the bending, manipulating and generating events. Moreover, the repeated events of bending, manipulating and generating are applied in a manner isolating the pulmonary veins from the epicardium of the heart.


Although only a few embodiments of the present inventions have been described in detail, it should be understood that the present inventions may be embodied in many other specific forms without departing from the spirit or scope of the inventions. Particularly, the invention has been described in terms of a microwave ablation instrument for cardiac applications, however, it should be appreciated that the described small diameter microwave ablation instrument could be used for a wide variety of non-cardiac ablation applications as well.


It should also be appreciated that the microwave antenna need not be a linear antenna. The concepts of the present invention may be applied to any kind of radiative structure, such as a helical dipole antenna, a printed antenna, a slow wave antenna, a lossy transmission antenna or the like. Furthermore, it should be appreciated that the transmission line does not absolutely have to be a coaxial cable. For example, the transmission line may be provided by a stripline, a microstrip line, a coplanar line, or the like.

Claims
  • 1. An ablation device for forming a lesion in targeted biological tissue, the device comprising: an ablation portion for delivering ablation energy to targeted biological tissue through a window portion in a surface of the ablation portion;a handle portion extending proximally of the ablation portion; anda grip portion attached to and extending distally from a distal end of the ablation portion is axially offset in a direction toward the window portion to facilitate rotational or translational manipulation of the ablation portion into position relative to the targeted biological tissue.
  • 2. The ablation device according to claim 1 in which the ablation portion and grip portion have similar flexibility.
  • 3. The ablation device according to claim 1 in which the ablation portion includes a high frequency antenna structure disposed therein offset toward the window portion to orient the antenna structure toward biological tissue in position adjacent the window portion.
RELATED APPLICATIONS

This application claims the benefit under 35 U.S.C. §120 as a division of application Ser. No. 10/219,598 filed on Aug. 14, 2002, which is a continuation of application Ser. No. 09/484,548, filed Jan. 18, 2000, now U.S. Pat. No. 7,033,352 entitled “A MICROWAVE ABLATION INSTRUMENT WITH FLEXIBLE ANTENNA ASSEMBLY AND METHOD,” which applications are incorporated herein in the entirety by this reference thereto.

US Referenced Citations (509)
Number Name Date Kind
1586645 Bierman Jun 1926 A
3598108 Jamshidi et al. Aug 1971 A
3827436 Stumpf et al. Aug 1974 A
3831607 Lindemann Aug 1974 A
3886944 Jamshidi Jun 1975 A
3976082 Schmitt Aug 1976 A
4011872 Komiya Mar 1977 A
4033357 Helland et al. Jul 1977 A
4045056 Kandakov et al. Aug 1977 A
4073287 Bradley et al. Feb 1978 A
4204549 Paglione May 1980 A
4244371 Farin Jan 1981 A
4268937 Grimshaw May 1981 A
4312364 Convert et al. Jan 1982 A
4409993 Furihata Oct 1983 A
4416276 Newton et al. Nov 1983 A
4445892 Hussein et al. May 1984 A
4448198 Turner May 1984 A
4462412 Turner Jul 1984 A
4465079 Dickhudt Aug 1984 A
4476872 Perlin Oct 1984 A
4494539 Zenitani et al. Jan 1985 A
4522212 Gelinas et al. Jun 1985 A
4564200 Loring et al. Jan 1986 A
4565200 Cosman Jan 1986 A
4573473 Hess Mar 1986 A
4583556 Hines et al. Apr 1986 A
4640983 Comte Feb 1987 A
4641646 Schultz et al. Feb 1987 A
4643186 Rosen et al. Feb 1987 A
4655219 Petruzzi Apr 1987 A
4657015 Irnich Apr 1987 A
4660571 Hess et al. Apr 1987 A
4681122 Winters et al. Jul 1987 A
4685459 Koch et al. Aug 1987 A
4699147 Chilson et al. Oct 1987 A
4700716 Kasevich et al. Oct 1987 A
4763668 Macek et al. Aug 1988 A
4785815 Cohen Nov 1988 A
4800899 Elliott Jan 1989 A
4823812 Eshel et al. Apr 1989 A
4825880 Stauffer et al. May 1989 A
4832048 Cohen May 1989 A
4841988 Fetter et al. Jun 1989 A
4841990 Kikuchi et al. Jun 1989 A
4881543 Trembly et al. Nov 1989 A
4891483 Kikuchi et al. Jan 1990 A
4920978 Colvin May 1990 A
4924863 Sterzer May 1990 A
4924864 Danzig May 1990 A
4932420 Goldstein Jun 1990 A
4938217 Lele Jul 1990 A
4945912 Langberg Aug 1990 A
4960134 Webster, Jr. Oct 1990 A
4966597 Cosman Oct 1990 A
4976711 Parins et al. Dec 1990 A
5007437 Sterzer Apr 1991 A
RE33590 Dory May 1991 E
5019076 Yamanashi et al. May 1991 A
5044375 Bach, Jr. et al. Sep 1991 A
5057106 Kasevich et al. Oct 1991 A
5078713 Varney Jan 1992 A
5080101 Dory Jan 1992 A
5080102 Dory Jan 1992 A
5085659 Rydell Feb 1992 A
5097845 Fetter et al. Mar 1992 A
5100388 Behl et al. Mar 1992 A
5104393 Isner et al. Apr 1992 A
5108390 Potocky et al. Apr 1992 A
5111822 Dory May 1992 A
5114403 Clarke et al. May 1992 A
5129396 Rosen et al. Jul 1992 A
5139496 Hed Aug 1992 A
5147355 Friedman et al. Sep 1992 A
5147357 Rose et al. Sep 1992 A
5150717 Rosen et al. Sep 1992 A
5156151 Imran Oct 1992 A
5158092 Glace Oct 1992 A
5171255 Rydell Dec 1992 A
5172699 Svenson et al. Dec 1992 A
5188122 Phipps et al. Feb 1993 A
5190054 Fetter et al. Mar 1993 A
5192278 Hayes et al. Mar 1993 A
5207672 Roth et al. May 1993 A
5207674 Hamilton May 1993 A
5222501 Ideker et al. Jun 1993 A
5230334 Klopotek Jul 1993 A
5230349 Langberg Jul 1993 A
5242441 Avitall Sep 1993 A
5246438 Langberg Sep 1993 A
5248312 Langberg Sep 1993 A
5263493 Avitall Nov 1993 A
5281213 Milder et al. Jan 1994 A
5281215 Milder Jan 1994 A
5281217 Edwards et al. Jan 1994 A
5293869 Edwards et al. Mar 1994 A
5295484 Marcus et al. Mar 1994 A
5295955 Rosen et al. Mar 1994 A
5300068 Rosar et al. Apr 1994 A
5300099 Rudie Apr 1994 A
5301687 Wong et al. Apr 1994 A
5304207 Stromer Apr 1994 A
5313943 Houser et al. May 1994 A
5314466 Stern et al. May 1994 A
5318525 West et al. Jun 1994 A
5323781 Ideker et al. Jun 1994 A
5327889 Imran Jul 1994 A
5334168 Hemmer Aug 1994 A
5341807 Nardella Aug 1994 A
5344431 Merritt et al. Sep 1994 A
5344441 Gronauer Sep 1994 A
5348554 Imran et al. Sep 1994 A
5358515 Hurter et al. Oct 1994 A
5364336 Carr Nov 1994 A
5364351 Heinzelman et al. Nov 1994 A
5364352 Cimino et al. Nov 1994 A
5364392 Warner et al. Nov 1994 A
5366490 Edwards et al. Nov 1994 A
5368592 Stern et al. Nov 1994 A
5369251 King et al. Nov 1994 A
5370644 Langberg Dec 1994 A
5370675 Edwards et al. Dec 1994 A
5370677 Rudie et al. Dec 1994 A
5370678 Edwards et al. Dec 1994 A
5374287 Rubin Dec 1994 A
5376094 Kline Dec 1994 A
5383876 Nardella Jan 1995 A
5383922 Zipes et al. Jan 1995 A
5391147 Imran et al. Feb 1995 A
5397304 Truckai Mar 1995 A
5398683 Edwards et al. Mar 1995 A
5402772 Moll et al. Apr 1995 A
5403312 Yates et al. Apr 1995 A
5405346 Grundy et al. Apr 1995 A
5405375 Ayers et al. Apr 1995 A
5405376 Mulier et al. Apr 1995 A
5415656 Tihon et al. May 1995 A
5417208 Winkler May 1995 A
5423807 Milder Jun 1995 A
5431649 Mulier et al. Jul 1995 A
5437665 Munro Aug 1995 A
5439006 Brennen et al. Aug 1995 A
5443489 Ben-Haim Aug 1995 A
5445193 Koeninger et al. Aug 1995 A
5450846 Goldreyer Sep 1995 A
5452733 Sterman et al. Sep 1995 A
5454370 Avitall Oct 1995 A
5454733 Watanabe et al. Oct 1995 A
5454807 Lennox et al. Oct 1995 A
5462544 Saksena et al. Oct 1995 A
5462545 Wang et al. Oct 1995 A
5464404 Abela et al. Nov 1995 A
5470308 Edwards et al. Nov 1995 A
5482037 Borghi Jan 1996 A
5484433 Taylor et al. Jan 1996 A
5487757 Truckai et al. Jan 1996 A
5492126 Hennige et al. Feb 1996 A
5494039 Onik et al. Feb 1996 A
5496271 Burton et al. Mar 1996 A
5496312 Klicek Mar 1996 A
5500012 Brucker et al. Mar 1996 A
5507743 Edwards et al. Apr 1996 A
5514131 Edwards et al. May 1996 A
5520188 Hennige et al. May 1996 A
5529820 Nomi et al. Jun 1996 A
5531677 Lundquist et al. Jul 1996 A
5536247 Thornton Jul 1996 A
5540681 Strul et al. Jul 1996 A
5540684 Hassler, Jr. Jul 1996 A
5545193 Fleischman et al. Aug 1996 A
5545200 West et al. Aug 1996 A
5549638 Burdette Aug 1996 A
5549644 Lundquist et al. Aug 1996 A
5549661 Kordis et al. Aug 1996 A
5569242 Lax et al. Oct 1996 A
5571088 Lennox et al. Nov 1996 A
5571215 Sterman et al. Nov 1996 A
5575766 Swartz et al. Nov 1996 A
5575810 Swanson et al. Nov 1996 A
5578030 Levin Nov 1996 A
5578067 Ekwall et al. Nov 1996 A
5581905 Huelsman et al. Dec 1996 A
5584830 Ladd et al. Dec 1996 A
5590657 Cain et al. Jan 1997 A
5593404 Costello et al. Jan 1997 A
5593405 Osypka Jan 1997 A
5599295 Rosen et al. Feb 1997 A
5599346 Baker et al. Feb 1997 A
5603697 Grundy et al. Feb 1997 A
5606974 Castellano et al. Mar 1997 A
5607389 Edwards et al. Mar 1997 A
5628771 Mizukawa et al. May 1997 A
5630837 Crowley May 1997 A
5640955 Ockuly et al. Jun 1997 A
5643255 Organ Jul 1997 A
5658280 Issa Aug 1997 A
5672172 Zupkas Sep 1997 A
5672174 Gough et al. Sep 1997 A
5673695 McGee et al. Oct 1997 A
5676692 Sanghvi et al. Oct 1997 A
5676693 LaFontaine Oct 1997 A
5681308 Edwards et al. Oct 1997 A
5683382 Lenihan et al. Nov 1997 A
5683384 Gough et al. Nov 1997 A
5687723 Avitall Nov 1997 A
5688267 Panescu et al. Nov 1997 A
5693078 Desai et al. Dec 1997 A
5693082 Warner et al. Dec 1997 A
5694701 Huelsman et al. Dec 1997 A
5697928 Walcott et al. Dec 1997 A
5707369 Vaitekunas et al. Jan 1998 A
5718226 Riza Feb 1998 A
5718241 Ben-Haim et al. Feb 1998 A
5720718 Rosen et al. Feb 1998 A
5720775 Larnard Feb 1998 A
5725523 Mueller Mar 1998 A
5730127 Avitall Mar 1998 A
5733280 Avitall Mar 1998 A
5733281 Nardella Mar 1998 A
5735280 Sherman et al. Apr 1998 A
5737384 Fenn Apr 1998 A
5738096 Ben-Haim Apr 1998 A
5741225 Lax et al. Apr 1998 A
5741249 Moss et al. Apr 1998 A
5743239 Iwase Apr 1998 A
5755760 Maguire et al. May 1998 A
5762066 Law et al. Jun 1998 A
5762626 Lundquist et al. Jun 1998 A
5769790 Watkins et al. Jun 1998 A
5769846 Edwards et al. Jun 1998 A
5782747 Zimmon Jul 1998 A
5782828 Chen et al. Jul 1998 A
5785706 Bednarek Jul 1998 A
5785707 Boyd et al. Jul 1998 A
5788692 Campbell et al. Aug 1998 A
5797905 Fleischman et al. Aug 1998 A
5797960 Stevens et al. Aug 1998 A
5800378 Edwards et al. Sep 1998 A
5800379 Edwards Sep 1998 A
5800413 Swartz et al. Sep 1998 A
5800428 Nelson et al. Sep 1998 A
5800482 Pomeranz et al. Sep 1998 A
5800494 Campbell et al. Sep 1998 A
5807309 Lundquist et al. Sep 1998 A
5807395 Mulier et al. Sep 1998 A
5810803 Moss et al. Sep 1998 A
5814028 Swartz et al. Sep 1998 A
5823197 Edwards Oct 1998 A
5823955 Kuck et al. Oct 1998 A
5823956 Roth et al. Oct 1998 A
5823962 Schaetzle et al. Oct 1998 A
5826576 West Oct 1998 A
5827216 Igo et al. Oct 1998 A
5829447 Stevens et al. Nov 1998 A
5836947 Fleischman et al. Nov 1998 A
5836990 Li Nov 1998 A
5840027 Swartz et al. Nov 1998 A
5840030 Ferek-Petric et al. Nov 1998 A
5842037 Haartsen Nov 1998 A
5843026 Edwards et al. Dec 1998 A
5843075 Taylor Dec 1998 A
5843171 Campbell et al. Dec 1998 A
5846238 Jackson et al. Dec 1998 A
5852860 Lorraine et al. Dec 1998 A
5853366 Dowlatshahi Dec 1998 A
5853368 Solomon et al. Dec 1998 A
5855614 Stevens et al. Jan 1999 A
5860920 McGee et al. Jan 1999 A
5861002 Desai Jan 1999 A
5861021 Thome et al. Jan 1999 A
5863290 Gough et al. Jan 1999 A
5868737 Taylor et al. Feb 1999 A
5871481 Kannenberg et al. Feb 1999 A
5871525 Edwards et al. Feb 1999 A
5873828 Fujio et al. Feb 1999 A
5873896 Ideker Feb 1999 A
5882302 Driscoll, Jr. et al. Mar 1999 A
5885278 Fleischman Mar 1999 A
5891134 Goble et al. Apr 1999 A
5895355 Schaer Apr 1999 A
5897553 Mulier et al. Apr 1999 A
5897554 Chia et al. Apr 1999 A
5899899 Arless et al. May 1999 A
5904709 Arndt et al. May 1999 A
5906580 Kline-Schoder et al. May 1999 A
5910129 Koblish et al. Jun 1999 A
5916213 Haissaguerre et al. Jun 1999 A
5919188 Shearon et al. Jul 1999 A
5921924 Avitall Jul 1999 A
5924424 Stevens et al. Jul 1999 A
5931810 Grabek Aug 1999 A
5938600 Van Vaals et al. Aug 1999 A
5938612 Kline-Schoder et al. Aug 1999 A
5938692 Rudie Aug 1999 A
5954662 Swanson et al. Sep 1999 A
5954665 Ben-Haim Sep 1999 A
5957842 Littmann et al. Sep 1999 A
5957969 Warner et al. Sep 1999 A
5964727 Edwards et al. Oct 1999 A
5964732 Willard Oct 1999 A
5964756 McGaffigan et al. Oct 1999 A
5971983 Lesh Oct 1999 A
5978714 Zadini et al. Nov 1999 A
5980697 Kolb et al. Nov 1999 A
5993389 Driscoll, Jr. et al. Nov 1999 A
5993445 Issa Nov 1999 A
5993447 Blewett et al. Nov 1999 A
5995875 Blewett et al. Nov 1999 A
6002955 Willems et al. Dec 1999 A
6004269 Crowley et al. Dec 1999 A
6007499 Martin et al. Dec 1999 A
6010516 Hulka Jan 2000 A
6027497 Daniel et al. Feb 2000 A
6027501 Goble et al. Feb 2000 A
6030382 Fleischman et al. Feb 2000 A
6032077 Pomeranz Feb 2000 A
6056735 Okada et al. May 2000 A
6059778 Sherman May 2000 A
6063077 Schaer May 2000 A
6063081 Mulier et al. May 2000 A
6064902 Haissaguerre et al. May 2000 A
6066094 Ben-Haim May 2000 A
6068628 Fanton et al. May 2000 A
6068629 Haissaguerre et al. May 2000 A
6071274 Thompson et al. Jun 2000 A
6071281 Burnside et al. Jun 2000 A
6076012 Swanson et al. Jun 2000 A
6083159 Driscoll, Jr. et al. Jul 2000 A
6086583 Ouchi Jul 2000 A
6090104 Webster, Jr. Jul 2000 A
6090105 Zepeda et al. Jul 2000 A
6097985 Kasevich et al. Aug 2000 A
6102886 Lundquist et al. Aug 2000 A
6106517 Zupkas Aug 2000 A
6106521 Blewett et al. Aug 2000 A
6106522 Fleischman et al. Aug 2000 A
6106524 Eggers et al. Aug 2000 A
6117101 Diederich et al. Sep 2000 A
6119041 Pomeranz et al. Sep 2000 A
6135971 Hutchinson et al. Oct 2000 A
6142994 Swanson et al. Nov 2000 A
6146378 Mukus et al. Nov 2000 A
6146379 Fleischman et al. Nov 2000 A
6152920 Thompson et al. Nov 2000 A
6161543 Cox et al. Dec 2000 A
6162216 Guziak et al. Dec 2000 A
6164283 Lesh Dec 2000 A
6165174 Jacobs et al. Dec 2000 A
6171303 Ben-Haim et al. Jan 2001 B1
6174309 Wrublewski et al. Jan 2001 B1
6178354 Gibson Jan 2001 B1
6182664 Cosgrove Feb 2001 B1
6190382 Ormsby et al. Feb 2001 B1
6200315 Gaiser et al. Mar 2001 B1
6206831 Suorsa et al. Mar 2001 B1
6210356 Anderson et al. Apr 2001 B1
6216027 Willis et al. Apr 2001 B1
6217530 Martin et al. Apr 2001 B1
6217573 Webster Apr 2001 B1
6224587 Gibson May 2001 B1
6231518 Grabek et al. May 2001 B1
6233490 Kasevich May 2001 B1
6235025 Swartz et al. May 2001 B1
6237605 Vaska et al. May 2001 B1
6241722 Dobak et al. Jun 2001 B1
6241728 Gaiser et al. Jun 2001 B1
6241754 Swanson et al. Jun 2001 B1
6245062 Berube et al. Jun 2001 B1
6245064 Lesh et al. Jun 2001 B1
6251128 Knopp et al. Jun 2001 B1
6273887 Yamauchi et al. Aug 2001 B1
6277113 Berube Aug 2001 B1
6283955 Pacala et al. Sep 2001 B1
6287302 Berube Sep 2001 B1
6289249 Arndt et al. Sep 2001 B1
6290699 Hall et al. Sep 2001 B1
6302880 Schaer Oct 2001 B1
6305378 Lesh Oct 2001 B1
6306124 Jones et al. Oct 2001 B1
6306132 Moorman et al. Oct 2001 B1
6309388 Fowler Oct 2001 B1
6311692 Vaska et al. Nov 2001 B1
6312425 Simpson et al. Nov 2001 B1
6312427 Berube et al. Nov 2001 B1
6314962 Vaska et al. Nov 2001 B1
6314963 Vaska et al. Nov 2001 B1
6315741 Martin et al. Nov 2001 B1
6322558 Taylor et al. Nov 2001 B1
6325796 Berube et al. Dec 2001 B1
6325797 Stewart et al. Dec 2001 B1
6332881 Carner et al. Dec 2001 B1
6346104 Daly et al. Feb 2002 B2
6355033 Moorman et al. Mar 2002 B1
6356790 Maguire et al. Mar 2002 B1
6358248 Mulier et al. Mar 2002 B1
6361531 Hissong Mar 2002 B1
6364876 Erb et al. Apr 2002 B1
6379348 Onik Apr 2002 B1
6383182 Berube et al. May 2002 B1
6402556 Lang et al. Jun 2002 B1
6413254 Hissong et al. Jul 2002 B1
6423057 He et al. Jul 2002 B1
6423059 Hanson et al. Jul 2002 B1
6428538 Blewett et al. Aug 2002 B1
6430426 Avitall Aug 2002 B2
6432067 Martin et al. Aug 2002 B1
6471696 Berube et al. Oct 2002 B1
6471697 Lesh Oct 2002 B1
6474340 Vaska et al. Nov 2002 B1
6484727 Vaska et al. Nov 2002 B1
6488639 Ribault et al. Dec 2002 B1
6488679 Swanson et al. Dec 2002 B1
6490474 Willis et al. Dec 2002 B1
6500133 Martin et al. Dec 2002 B2
6502575 Jacobs et al. Jan 2003 B1
6502576 Lesh Jan 2003 B1
6508774 Acker et al. Jan 2003 B1
6514246 Swanson et al. Feb 2003 B1
6514249 Maguire et al. Feb 2003 B1
6517568 Sharkey et al. Feb 2003 B1
6526320 Mitchell Feb 2003 B2
6527767 Wang et al. Mar 2003 B2
6527768 Berube Mar 2003 B2
6529756 Phan et al. Mar 2003 B1
6533780 Laird et al. Mar 2003 B1
6542781 Koblish et al. Apr 2003 B1
6576875 Kleffner et al. Jun 2003 B1
6586040 Von Falkenhausen Jul 2003 B1
6599280 Pynson et al. Jul 2003 B1
6610055 Swanson et al. Aug 2003 B1
6645200 Koblish et al. Nov 2003 B1
6645202 Pless et al. Nov 2003 B1
6652513 Panescu et al. Nov 2003 B2
6652515 Maguire et al. Nov 2003 B1
6652518 Wellman et al. Nov 2003 B2
6663622 Foley et al. Dec 2003 B1
6673068 Berube Jan 2004 B1
6689062 Mesallum Feb 2004 B1
6689128 Sliwa, Jr. et al. Feb 2004 B2
6701931 Sliwa, Jr. et al. Mar 2004 B2
6719755 Sliwa, Jr. et al. Apr 2004 B2
6723092 Brown et al. Apr 2004 B2
6802840 Chin et al. Oct 2004 B2
6805709 Schaldach et al. Oct 2004 B1
6808536 Wright et al. Oct 2004 B2
20010031961 Hooven Oct 2001 A1
20010039416 Moorman et al. Nov 2001 A1
20020001655 Kuechle et al. Jan 2002 A1
20020017306 Cox et al. Feb 2002 A1
20020032440 Hooven et al. Mar 2002 A1
20020042610 Sliwa, Jr. et al. Apr 2002 A1
20020042611 Silwa et al. Apr 2002 A1
20020045895 Sliwa, Jr. et al. Apr 2002 A1
20020058932 Moorman May 2002 A1
20020087151 Mody et al. Jul 2002 A1
20020087157 Sliwa, Jr. et al. Jul 2002 A1
20020091382 Hooven Jul 2002 A1
20020091383 Hooven Jul 2002 A1
20020091384 Hooven et al. Jul 2002 A1
20020095145 Simons et al. Jul 2002 A1
20020103484 Hooven Aug 2002 A1
20020107513 Hooven Aug 2002 A1
20020107514 Hooven Aug 2002 A1
20020111613 Berube Aug 2002 A1
20020115993 Hooven Aug 2002 A1
20020120263 Brown et al. Aug 2002 A1
20020120267 Phan Aug 2002 A1
20020120316 Hooven et al. Aug 2002 A1
20020128639 Pless et al. Sep 2002 A1
20020128642 Berube et al. Sep 2002 A1
20020173784 Sliwa, Jr. et al. Nov 2002 A1
20020193783 Gauthier et al. Dec 2002 A1
20020193786 Berube et al. Dec 2002 A1
20030024537 Cox et al. Feb 2003 A1
20030028187 Vaska et al. Feb 2003 A1
20030029462 Cox et al. Feb 2003 A1
20030032952 Hooven Feb 2003 A1
20030050630 Mody et al. Mar 2003 A1
20030050631 Mody et al. Mar 2003 A1
20030065327 Wellman et al. Apr 2003 A1
20030069572 Wellman et al. Apr 2003 A1
20030069574 Sliwa, Jr. et al. Apr 2003 A1
20030069575 Fatt et al. Apr 2003 A1
20030069577 Vaska et al. Apr 2003 A1
20030073988 Berube et al. Apr 2003 A1
20030073992 Sliwa, Jr. et al. Apr 2003 A1
20030078571 Sliwa, Jr. et al. Apr 2003 A1
20030079753 Vaska et al. May 2003 A1
20030083654 Fatt et al. May 2003 A1
20030093068 Hooven May 2003 A1
20030097126 Woloszko et al. May 2003 A1
20030109868 Fatt et al. Jun 2003 A1
20030125666 Kashara et al. Jul 2003 A1
20030125725 Woodard et al. Jul 2003 A1
20030125729 Hooven et al. Jul 2003 A1
20030136951 Hung Jul 2003 A1
20030158547 Phan Aug 2003 A1
20030158548 Phan et al. Aug 2003 A1
20030163128 Patil et al. Aug 2003 A1
20030171745 Francischelli et al. Sep 2003 A1
20030176764 Fiegel et al. Sep 2003 A1
20030181907 Lindsay Sep 2003 A1
20040002045 Wellman et al. Jan 2004 A1
20040044340 Francischelli et al. Mar 2004 A1
20040049179 Francischelli et al. Mar 2004 A1
20040049208 Hill et al. Mar 2004 A1
20040068274 Hooven Apr 2004 A1
20040092990 Opie et al. May 2004 A1
20040106918 Cox et al. Jun 2004 A1
Foreign Referenced Citations (48)
Number Date Country
0048402 Aug 1985 EP
0358 336 Mar 1990 EP
0139607 Apr 1990 EP
0248758 Aug 1991 EP
0628322 Dec 1994 EP
0738501 May 2000 EP
1005838 Jun 2000 EP
1042990 Oct 2000 EP
0655 225 Mar 2001 EP
118310 Jul 2001 EP
0839547 Sep 2003 EP
WO 9308757 May 1993 WO
WO 9315664 Aug 1993 WO
WO 9320767 Oct 1993 WO
WO 9320768 Oct 1993 WO
WO 9320886 Oct 1993 WO
WO 9320893 Oct 1993 WO
WO 9324065 Dec 1993 WO
WO 9302204 Feb 1994 WO
WO 9505212 Feb 1995 WO
WO 9518575 Jul 1995 WO
WO 9626675 Sep 1996 WO
WO 9535469 Nov 1996 WO
WO 9635496 Nov 1996 WO
WO 9636397 Nov 1996 WO
WO 9742893 Nov 1997 WO
WO 9744092 Nov 1997 WO
WO 9806341 Feb 1998 WO
WO 9817185 Apr 1998 WO
WO 9817187 Apr 1998 WO
WO 9844857 Oct 1998 WO
WO 9904696 Feb 1999 WO
WO 9908613 Feb 1999 WO
WO 9934860 Jul 1999 WO
WO 9959486 Nov 1999 WO
WO 0016850 Mar 2000 WO
WO 0035363 Jun 2000 WO
WO 0056239 Sep 2000 WO
WO 0105306 Jan 2001 WO
WO 0115616 Mar 2001 WO
WO 0141664 Jun 2001 WO
WO 0158373 Aug 2001 WO
WO 0180755 Nov 2001 WO
WO 0182814 Nov 2001 WO
WO 0201655 Jan 2002 WO
WO 0205722 Jan 2002 WO
WO 0238052 May 2002 WO
WO 02060523 Aug 2002 WO
Related Publications (1)
Number Date Country
20060138122 A1 Jun 2006 US
Divisions (1)
Number Date Country
Parent 10219598 Aug 2002 US
Child 11356917 US
Continuations (1)
Number Date Country
Parent 09484548 Jan 2000 US
Child 10219598 US